The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo
Open accessAbstract
Many functions have been assigned to the von Hippel-Lindau tumor suppressor gene product (pVHL), including targeting the alpha subunits of the heterodimeric transcription factor HIF (hypoxia-inducible factor) for destruction. The binding of pVHL to HIFalpha requires that HIFalpha be hydroxylated on one of two prolyl residues. We introduced HIF1alpha and HIF2alpha variants that cannot be hydroxylated on these sites into the ubiquitously expressed ROSA26 locus along with a Lox-stop-Lox cassette that renders their expression Cre-dependent. Expression of the HIF2alpha variant in the skin and liver induced changes that were highly similar to those seen when pVHL is lost in these organs. Dual expression of the HIF1alpha and HIF2alpha variants in liver, however, more closely phenocopied the changes seen after pVHL inactivation than did the HIF2alpha variant alone. Moreover, gene expression profiling confirmed that the genes regulated by HIF1alpha and HIF2alpha in the liver are overlapping but non-identical. Therefore, the pathological changes caused by pVHL inactivation in skin and liver are due largely to dysregulation of HIF target genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Over-expression of non-degradable HIF-2α in hepatocytes produced erythrocytosis, whereas over-expression of HIF-1α did not. 110”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [110]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,328
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 5,237
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasPreprint
Jackson, E. L., Willis, N. A., Mercer, K. L., Bronson, R. T., Crowley, D. G., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,927
Cited by
Sorted by citations
Items 101–200 of 235
Song, F., Lee, W. D., Marmo, T., Ji, X., Song, C., Liao, X., Seeley, R. A., Yao, L., Liu, H., & Long, F. (2023) · eLife · doi:10.7554/elife.85714 · Cited by 57
Macías, D., Fernández‐Agüera, M. C., Bonilla, V., & López‐Barneo, J. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404153 · Cited by 52
Hypoxia-inducible factor 2α is a negative regulator of osteoblastogenesis and bone mass accrual
Merceron, C., Ranganathan, K., Wang, E. Y., Tata, Z., Makkapati, S., Khan, M. P., Mangiavini, L., Yao, Q., Castellini, L., Lévi, B., et al. (2019) · Bone Research · doi:10.1038/s41413-019-0045-z · Cited by 54
Kucejová, B., Sunny, N. E., Nguyen, A. D., Hallac, R. R., Fu, X., Peña‐Llopis, S., Mason, R. P., DeBerardinis, R. J., Xie, X.-J., DeBose‐Boyd, R. A., et al. (2011) · Oncogene · doi:10.1038/onc.2010.587 · Cited by 51
Hypoxia and Metabolism in Cancer
Bensaad, K., & Harris, A. L. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6_1 · Cited by 49
Wesolowski, S. R., Mulligan, C. M., Janssen, R. C., Baker, P. R., Bergman, B. C., D’Alessandro, A., Nemkov, T. G., Maclean, K. N., Jiang, H., Dean, T. A., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.09.008 · Cited by 48
Hypoxia-Inducible Factor Prolyl 4-Hydroxylases and Metabolism
Koivunen, P., & Kietzmann, T. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.10.004 · Cited by 47
Hasanov, E., & Jonasch, E. W. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1925248 · Cited by 47
Treatment of erythropoietin deficiency in mice with systemically administered siRNA
Querbes, W., Bogorad, R. L., Moslehi, J., Wong, J., Chan, A. Y., Bulgakova, E., Kuchimanchi, S., Akinc, A., Fitzgerald, K., Koteliansky, V., et al. (2012) · Blood · doi:10.1182/blood-2012-04-423715 · Cited by 45
Hypoxia Induces Dysregulation of Lipid Metabolism in HepG2 Cells via Activation of HIF-2a
Cao, R., Zhao, X., Li, S., Zhou, H., Chen, W., Ren, L., Zhou, X., Zhang, H., & Shi, R. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000366348 · Cited by 45
The von Hippel‐Lindau Tumor Suppressor Protein: An Update
Kaelin, W. G. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35019-2 · Cited by 45
STAT3 or USF2 Contributes to HIF Target Gene Specificity
Pawlus, M. R., Wang, L., Murakami, A., Dai, G., & Hu, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072358 · Cited by 44
Kron, P., Linecker, M., Limani, P., Schlegel, A. A., Kambakamba, P., Lehn, J., Nicolau, C. S., Graf, R., Humar, B., & Clavien, P. (2016) · Hepatology · doi:10.1002/hep.28809 · Cited by 45
All along the watchtower: Is the cilium a tumor suppressor organelle?
Mans, D. A., Voest, E. E., & Giles, R. H. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.02.002 · Cited by 43
Genetic causes of erythrocytosis and the oxygen-sensing pathway
Lee, F. S. (2008) · Blood Reviews · doi:10.1016/j.blre.2008.04.003 · Cited by 43
Selective tubular activation of hypoxia-inducible factor-2α has dual effects on renal fibrosis
Kong, K. H., Oh, H. J., Lim, B. J., Kim, M., Han, K., Choi, Y., Kwon, K., Nam, B. Y., Park, K. S., Park, J. T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11829-2 · Cited by 42
Yan, Y., Wu, X., Wang, P., Zhang, S., Sun, L., Zhao, Y., Zeng, G., Liu, B., Xu, G., Liu, H., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101742 · Cited by 39
Gilglioni, E. H., Chang, J., Duijst, S., Go, S., Adam, A. A. A., Hoekstra, R., Verhoeven, A. J., Ishii‐Iwamoto, E. L., & Elferink, R. P. J. O. (2018) · Hepatology Communications · doi:10.1002/hep4.1140 · Cited by 40
Endothelial HIF-2α as a Key Endogenous Mediator Preventing Emphysema
Pasupneti, S., Tian, W., Tu, A. B., Dahms, P. A., Granucci, E. J., Gandjeva, A., Xiang, M., Butcher, E. C., Semenza, G. L., Tuder, R. M., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202001-0078oc · Cited by 38
Xia, Q., Wu, F., Wu, W., Dong, H., Huang, Z., Xu, L., Lu, F., & Gong, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112955 · Cited by 39
van der Graaff, D., Kwanten, W. J., & Francque, S. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.11.014 · Cited by 38
Wang, C.-H., Liu, H.-M., Chang, Z., Huang, T., & Lee, T.-Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157841 · Cited by 37
Oxygen-dependent Regulation of Erythropoietin Receptor Turnover and Signaling
Heir, P., Srikumar, T., Bikopoulos, G. J., Bunda, S., Poon, B., Lee, J. E., Raught, B., & Ohh, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.694562 · Cited by 36
Hypoxia-inducible factor 1 alpha limits dendritic cell stimulation of CD8 T cell immunity
Tran, C. W., Gold, M. J., Garcia-Batres, C. R., Tai, K., Elford, A. R., Himmel, M. E., Elia, A., & Ohashi, P. S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244366 · Cited by 35
Barrier integrity and chronic inflammation mediated by HIF-1 impact on intestinal tumorigenesis
Robrahn, L., Jiao, L. R., & Cramer, T. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.07.002 · Cited by 32
Kidney Cancer: Now Available in a New Flavor
Kaelin, W. G. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.11.005 · Cited by 34
Schlisio, S. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00881.x · Cited by 33
Deficiency of the oxygen sensor PHD1 augments liver regeneration after partial hepatectomy
Mollenhauer, M., Kiss, J., Dudda, J., Kirchberg, J., Rahbari, N. N., Radhakrishnan, P., Niemietz, T., Rausch, V., Weitz, J., & Schneider, M. A. (2012) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-012-0998-5 · Cited by 31
Chen, R.-Q., Yang, Q., Chen, Y., Oliveira, V. A., Dalton, W. S., Fearns, C., & Lee, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014316 · Cited by 30
Dehn, S., DeBerge, M., Yeap, X., Yvan‐Charvet, L., Fang, D., Eltzschig, H. K., Miller, S. D., & Thorp, E. B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600402 · Cited by 31
Decreased lymphatic HIF-2α accentuates lymphatic remodeling in lymphedema
Jiang, X., Tian, W., Granucci, E. J., Tu, A. B., Kim, D., Dahms, P. A., Pasupneti, S., Peng, G., Kim, Y., Lim, A. H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136164 · Cited by 28
The Endoplasmic Reticulum Cargo Receptor SURF4 Facilitates Efficient Erythropoietin Secretion
Lin, Z., King, R., Tang, V. T., Myers, G., Balbin-Cuesta, G., Friedman, A. D., McGee, B. M., Desch, K. C., Ozel, A. B., Siemieniak, D. R., et al. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00180-20 · Cited by 30
Lee, Y. S., Riopel, M., Cabrales, P., & Bandyopadhyay, G. K. (2019) · Science Advances · doi:10.1126/sciadv.aaw4176 · Cited by 30
Beyond the hypoxia-inducible factor-centric tumour suppressor model of von Hippel-Lindau
Roberts, A. M., & Ohh, M. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f310de · Cited by 29
Bangiyeva, V., Rosenbloom, A., Alexander, A. E., Isanova, B., Popko, T., & Schoenfeld, A. R. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-229 · Cited by 29
Wang, J., Hayashi, Y., Yokota, A., Xu, Z., Zhang, Y., Huang, R., Yan, X., Liu, H., Ma, L., Azam, M., et al. (2017) · Haematologica · doi:10.3324/haematol.2017.172775 · Cited by 27
Okumura, F., Uematsu, K., Byrne, S. D., Hirano, M., Akiko, J.-O., Nishikimi, A., Shuin, T., Fukui, Y., Nakatsukasa, K., & Kamura, T. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00067-16 · Cited by 28
The von Hippel–Lindau Tumor Suppressor Protein
Kaelin, W. G. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050527 · Cited by 24
Hurst, J. H. (2016) · Journal of Clinical Investigation · doi:10.1172/jci90055 · Cited by 27
Induction of DEPP1 by HIF Mediates Multiple Hallmarks of Ischemic Cardiomyopathy
Wyant, G. A., Jiang, Q., Singh, M., Qayyum, S., Levrero, C., Maron, B. A., & Kaelin, W. G. (2024) · Circulation · doi:10.1161/circulationaha.123.066628 · Cited by 24
Lai, Y., Qiao, M., Song, M., Weintraub, S. T., & Shiio, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016975 · Cited by 23
Prolyl hydroxylase domain-2 (PHD2) inhibition may be a better therapeutic strategy in renal anemia
Soni, H. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.02.008 · Cited by 21
The road to systemic therapy in von Hippel-Lindau (VHL) disease: Are we there yet?
Shepherd, S. T. C., Drake, W. M., & Turajlic, S. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.12.011 · Cited by 21
Laitakari, A., Tapio, J., Mäkelä, K. A., Herzig, K., Dengler, F., Gylling, H., Walkinshaw, G., Myllyharju, J., Dimova, E. Y., Serpi, R., et al. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01903-0 · Cited by 21
A mitofusin 2/HIF1α axis sets a maturation checkpoint in regenerating skeletal muscle
Wang, X., Jia, Y., Zhao, J., Lesner, N. P., Menezes, C. J., Shelton, S. D., Venigalla, S. S. K., Xu, J., Cai, C., & Mishra, P. (2022) · Journal of Clinical Investigation · doi:10.1172/jci161638 · Cited by 20
Chassen, S. S., Berry, K. A. Z., Raymond-Whish, S., Driver, C., Hobbins, J. C., & Powell, T. L. (2022) · Cells · doi:10.3390/cells11193110 · Cited by 20
Olufsen, M., Cangialosi, M. V., & Arukwe, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102485 · Cited by 20
RSUME inhibits VHL and regulates its tumor suppressor function
Gerez, J., Tedesco, L., Bonfiglio, J. J., Fuertes, M., Barontini, M., Silberstein, S., Wu, Y., Renner, U., Páez-Pereda, M., Holsboer, F., et al. (2014) · Oncogene · doi:10.1038/onc.2014.407 · Cited by 20
Identification of an Alternative Mechanism of Degradation of the Hypoxia-inducible Factor-1α
André, H., & Pereira, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805919200 · Cited by 20
Geynisman, D. M., Maranchie, J. K., Ball, M. W., Bratslavsky, G., & Singer, E. A. (2021) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2021.04.038 · Cited by 22
Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents
Hazlehurst, J., Lim, T. R., Charlton, C. A., Miller, J. J. J. J., Gathercole, L., Cornfield, T., Nikolaou, N., Harris, S., Moolla, A., Othonos, N., et al. (2022) · Metabolism Open · doi:10.1016/j.metop.2022.100177 · Cited by 19
HIF-2α-dependent induction of miR-29a restrains TH1 activity during T cell dependent colitis
Czopik, A. K., McNamee, E. N., Vaughn, V., Huang, X., Bang, I. H., Clark, T., Wang, Y., Ruan, W., Nguyen, T. T., Masterson, J. C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52113-y · Cited by 21
Endocrine targets of hypoxia-inducible factors
Lee, H.-C., & Tsai, S. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0653 · Cited by 22
HIF2 Inhibitor Joins the Kidney Cancer Armamentarium
Kaelin, W. G. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.5254 · Cited by 18
Lactate metabolism is essential in early-onset mitochondrial myopathy
Chen, Z., Bordieanu, B., Kesavan, R., Lesner, N. P., Venigalla, S. S. K., Shelton, S. D., DeBerardinis, R. J., & Mishra, P. (2023) · Science Advances · doi:10.1126/sciadv.add3216 · Cited by 18
Impaired expression of HIF-2α induces compensatory expression of HIF-1α for the recovery from anemia
Tsuboi, I., Yamashita, T., Nagano, M., Kimura, K., Salazar, G. T., & Ohneda, O. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24899 · Cited by 19
Hypoxic‐ischemic gene expression profile in the isolated variant of biliary atresia
Fratta, L. X. S., Hoss, G. R. W., Longo, L., Cruz, C. U., da Silveira, T. R., Vieira, S. M. G., Kieling, C. O., & dos Santos, J. L. (2015) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.297 · Cited by 18
Yoon, D., Okhotin, D., Kim, B., Okhotina, Y., Okhotin, D. J., Miasnikova, G., Sergueeva, A., Polyakova, L. A., Maslow, A., Lee, Y., et al. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0599-0 · Cited by 17
Rana, H. Q., Koeller, D. R., Schwartz, A., Manning, D. K., Schneider, K. A., Krajewski, K. M., Choueiri, T. K., Lindeman, N. I., Garber, J. E., & Ghazani, A. A. (2021) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2021.104359 · Cited by 16
UBE3B promotes breast cancer progression by antagonizing HIF-2α degradation
Wang, Y., Liu, X., Wang, M., Wang, Y., Wang, S., Jin, L., Liu, M., Zhou, J. Y., & Chen, Y. (2023) · Oncogene · doi:10.1038/s41388-023-02842-z · Cited by 16
Transgenic Models to Understand Hypoxia‐Inducible Factor Function
Doedens, A. L., & Johnson, R. S. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35005-2 · Cited by 16
Schofield, H. K., Tandon, M., Park, M.-J., Halbrook, C. J., Ramakrishnan, S. K., Kim, E. C., Shi, J., Omary, M. B., Shah, Y. M., Esni, F., et al. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.10.008 · Cited by 15
Regulation of hypoxia-inducible factor 2-a is essential for integrity of the glomerular barrier
Ding, M., Coward, R. J., Jeansson, M., Kim, W., & Quaggin, S. E. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00416.2012 · Cited by 15
Genetic modification of hypoxia signaling in animal models and its effect on cancer
García-Heredia, J. M., Felipe‐Abrio, B., Cano, D. A., & Carnero, A. (2014) · Clinical & Translational Oncology · doi:10.1007/s12094-014-1236-0 · Cited by 15
Increased expression of transglutaminase 2 drives glycolytic metabolism in renal carcinoma cells
Ku, B. M., Lee, C. H., Lee, S.-H., & Kim, S. (2014) · Amino Acids · doi:10.1007/s00726-014-1714-2 · Cited by 14
HIF1α and HIF2α Exert Distinct Nutrient Preferences in Renal Cells
Arreola, A., Cowey, C. L., Coloff, J. L., Rathmell, J. C., & Rathmell, W. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098705 · Cited by 14
HIF1 activation safeguards cortical bone formation against impaired oxidative phosphorylation
Khan, M. P., Sabini, E., Beigel, K., Lanzolla, G., Laslow, B., Wang, D., Merceron, C., Giaccia, A. J., Long, F., Taylor, D. M., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.182330 · Cited by 13
Hypoxia-induced factor and its role in liver fibrosis
Omar, J. M., Hai, Y., & Jin, S. (2022) · PeerJ · doi:10.7717/peerj.14299 · Cited by 16
Associations between HIFs and tumor immune checkpoints: mechanism and therapy
Liu, J., Jiang, Y., Chen, L., Qian, Z., & Zhang, Y. (2024) · Discover Oncology · doi:10.1007/s12672-023-00836-7 · Cited by 13
Stransky, L. A., Gao, W., Schmidt, L. S., Bi, K., Ricketts, C. J., Ramesh, V., James, A. E., Difilippantonio, S., Ileva, L. V., Kalen, J. D., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2408549121 · Cited by 12
Chatterjee, N., Das, S., Bose, D., Banerjee, S., Jha, T., & Saha, K. D. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a1113-582r · Cited by 13
Influence of hypoxia-dependent factors on the progression of neuroblastoma
Ameis, H. M., Drenckhan, A., Freytag, M., Izbicki, J. R., Supuran, C. T., Reinshagen, K., Holland-Cunz, S. G., & Gros, S. J. (2015) · Pediatric Surgery International · doi:10.1007/s00383-015-3831-8 · Cited by 13
Kim, D.-A., Lee, M., Oh, H. J., Kim, M., & Kong, K. H. (2023) · BMB Reports · doi:10.5483/bmbrep.2022-0145 · Cited by 13
Pfander, C., Knauth, K., Dambacher, S., & Buchberger, A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm932 · Cited by 13
DeBerge, M., Schroth, S. L., Du, F., Yeap, X. Y., Wang, J.-J., Zhang, Z. J., Ansari, M. J., Scott, E. A., & Thorp, E. B. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2319623121 · Cited by 12
Prolyl-hydroxylase inhibitors for the treatment of anemia in chronic kidney disease
McMahon, G. M., & Singh, A. K. (2019) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000554 · Cited by 12
Reynoso-Roldán, A., Roldán, M. L., Cancino‐Díaz, J. C., Rodríguez–Martínez, S., & Cancino-Diaz, M. E. (2012) · Clinical and investigative medicine · doi:10.25011/cim.v35i6.19205 · Cited by 12
New cancer targets emerging from studies of the Von Hippel‐Lindau tumor suppressor protein
Kaelin, W. G. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05781.x · Cited by 12
Molecular Biology of Kidney Cancer
Kaelin, W. G. (2015) · Springer eBooks · doi:10.1007/978-3-319-17903-2_3 · Cited by 12
Abu‐Remaileh, M., Persky, N. S., Lee, Y., Root, D. E., & Kaelin, W. G. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2410356121 · Cited by 9
Mendoza, S. V., Murugesh, D. K., Christiansen, B., Genetos, Z. O., Loots, G. G., Genetos, D. C., & Yellowley, C. E. (2023) · JBMR Plus · doi:10.1002/jbm4.10724 · Cited by 9
Manipulation of the HIF–Vegf pathway rescues methyl tert-butyl ether (MTBE)-induced vascular lesions
Bonventre, J. A., Kung, T. S., White, L. A., & Cooper, K. R. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.10.008 · Cited by 9
Oxygen sensing; a stunningly elegant molecular machinery highjacked in cancer
Claesson, L. (2020) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2020.1769231 · Cited by 10
Hif-2α programs oxygen chemosensitivity in chromaffin cells
Prange‐Barczynska, M., Jones, H. A., Sugimoto, Y., Cheng, X., Lima, J. D. C. C., Ratnayaka, I., Douglas, G., Buckler, K. J., Ratcliffe, P. J., Keeley, T. P., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci174661 · Cited by 12
Angiotensin II Differentially Regulates Morg1 Expression in Kidney Cells
Bondeva, T., Heinzig, J., Franke, S., & Wolf, G. (2012) · American Journal of Nephrology · doi:10.1159/000337922 · Cited by 8
Katayama, H., Furuhashi, M., Umetsu, A., Hikage, F., Watanabe, M., Ohguro, H., & Ida, Y. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb43030121 · Cited by 8
Overexpression of HIF-2α in pancreatic β cells does not alter glucose homeostasis
Brunt, J. J., Shi, S. Y., Schroer, S. A., Sivasubramaniyam, T., Cai, E. P., & Woo, M. (2014) · Islets · doi:10.1080/19382014.2015.1006075 · Cited by 8
Tavakkoli, M., Khodashahi, R., Aliakbarian, M., Rahimi, H., Ashrafzadeh, K., Ferns, G. A., Khaleghi, E., & Arjmand, M. (2023) · Current Molecular Pharmacology · doi:10.2174/0118761429246636230919122745 · Cited by 7
Yao, X., Mai, X., Tian, Y., Liu, Y., Jin, G., Li, Z., Chen, S., Dai, X., Huang, L., Fan, Z., et al. (2025) · Science China Life Sciences · doi:10.1007/s11427-023-2586-x · Cited by 7
Research Translation and Personalized Medicine
Brugarolas, J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2400-0_8 · Cited by 7
Bishop, T., & Ratcliffe, P. J. (2025) · Physiology · doi:10.1152/physiol.00043.2024 · Cited by 6
Genetic insights into the hypoxia-inducible factor (HIF) pathway
Kiriakidis, S., Esteban, M. A., & Maxwell, P. H. (2007) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2006.12.009 · Cited by 6
HIF‐2α/ARNT complex regulates hair development via induction of p21 Waf1/Cip1 and p27 Kip1
Imamura, Y., Tomita, S., Imanishi, M., Kihira, Y., Ikeda, Y., Ishizawa, K., Tsuchiya, K., & Tamaki, T. (2014) · The FASEB Journal · doi:10.1096/fj.13-244079 · Cited by 6
HIF2 Regulates Intestinal Wnt5a Expression
García, C. J. G., Acevedo-Diaz, A., Kumari, N., Govindaraju, S., Bonilla, M. D. L. C., Lucas, F. A. S., Nguyen, N. D., Jiménez-Sacarello, I., Piwnica-Worms, H. M., Maitra, A., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.769385 · Cited by 5
Osteocytic oxygen sensing: Distinct impacts of VHL and HIF-2alpha on bone integrity
Mendoza, S. V., Wells, K. V., Murugesh, D. K., Hum, N. R., Sebastian, A., Gorman, B. M., Wong, A., Osipov, B., Christiansen, B., Loots, G. G., et al. (2024) · Bone · doi:10.1016/j.bone.2024.117339 · Cited by 5
Stabilization of HIF-2α impacts pancreas growth
Flores‐Martínez, Á., García-Núñez, A., Rojas, A., & Cano, D. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-32054-5 · Cited by 5
Johnston, S. N., Tsingas, M., Ain, R., Barve, R. A., & Risbud, M. V. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1360376 · Cited by 5
The multi-dimensional role of intestinal HIFs in liver pathobiology
Ouyang, X., & Mehal, W. Z. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.07.012 · Cited by 4
Portal Hypertension in NASH: Is It Different from Other Aetiologies?
Francque, S., Kwanten, W. J., & van der Graaff, D. (2019) · Current Hepatology Reports · doi:10.1007/s11901-019-00459-z · Cited by 5
Zhou, C., Zhang, Y., Ye, Z., Zhang, Y., He, P., Liu, M., Yang, S., Gan, X., Xiang, H., Huang, Y., et al. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.07.007 · Cited by 3
Metadata
- Authors
- Kim, W. Y., Safran, M., Buckley, M. R., Ebert, B. L., Glickman, J., Bosenberg, M., Regan, M., & Kaelin, W. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- University of Vermont (US)
- Harvard University (US)
- Corresponding author
- Kaelin, William G
- ORCID
- Venue
- The EMBO Journal
- Published
- 2006-09-14
- Volume
- 25
- Issue
- 19
- Pages
- 4650-4662
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC1589988
- OpenAlex
- W2097654747
- Cited by
- 235
- References
- 58
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 13 · 2023: 11 · 2022: 9 · 2021: 11 · 2020: 10 · 2019: 12 · 2018: 13 · 2017: 6 · 2016: 10 · 2015: 10 · 2014: 25 · 2013: 14 · 2012: 12
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The EMBO Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Cancer Institute (T32CA009172)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- von Hippel-Lindau tumor suppressor, hypoxia-inducible factor alpha, HIF-1α, HIF-2α, prolyl hydroxylation, phenocopy, Rosa26 locus, Cre-loxP system, liver, skin, HIF target genes, gene expression profiling, tumor suppressor inactivation
- MeSH terms
- Epidermal Cells, Endothelial PAS Domain-Containing Protein 1, Animals, Blood Vessels, Body Weight, Epidermis, Gene Expression Regulation, HeLa Cells, Humans, Hydroxylation, Liver, Mice, Inbred BALB C, Mice, Mutant Strains, Organ Size, Phenotype, Proline, Recombination, Genetic, Hepatocytes, Cell Proliferation, Mice, Basic Helix-Loop-Helix Proteins, Basic Helix-Loop-Helix Transcription Factors, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review